Refuge Biotechnologies
Latest round
- Series B
Last raised
- May 2018
Total raised
- $25M
Investors
- 8
About Refuge Biotechnologies
Refuge Biotechnologies, Inc.Founded in 2015 and headquartered in Menlo Park, US, Refuge Biotechnologies specializes in biotechnological advancements.Refuge Biotech specializes in developing innovative biotechnological solutions aimed at addressing critical challenges in healthcare and agriculture. The core product offerings comprise advanced biopharmaceuticals and genetic engineering tools designed to enhance treatment efficacy for various diseases and improve crop resilience in adverse environmental conditions. These products are tailored to meet the needs of healthcare providers, farmers, and research institutions. With a focus on precision medicine and sustainable agricultural practices, the company serves a diverse clientele across key geographical markets, including North America, Europe, and parts of Asia.Refuge Biotech generates revenue through a combination of direct sales and strategic partnerships, primarily engaging in B2B transactions with healthcare providers and agricultural enterprises. The company's revenue model includes subscriptions for access to proprietary technology platforms, licensing agreements for its biopharmaceutical products, and direct sales of its genetically engineered solutions. Transactions often occur through long-term contracts that ensure a steady stream of income, with clients committing to annual purchases based on projected needs. The pricing structure is aligned with industry standards, reflecting the value of its flagship biopharmaceuticals and agricultural products.Refuge Biotechnologies is actively pursuing the development of new biopharmaceutical products, with plans to launch several innovative treatments by the end of 2024. The company aims to expand its market presence in Asia and Europe, targeting specific regions by the third quarter of 2025. Additionally, 6 Dimensions Capital has exited its stake in the company, which may influence future strategic partnerships.
Who invested in Refuge Biotechnologies
8 investors across 1 round
See all investors in Refuge Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 2, 2018
Amount
$25M
Investors
Questions about Refuge Biotechnologies
Who invested in Refuge Biotechnologies?
Refuge Biotechnologies has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Refuge Biotechnologies raised?
Refuge Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Refuge Biotechnologies last raise money?
Refuge Biotechnologies's most recent round on record is a Series B, in May 2018.
What does Refuge Biotechnologies do?
Refuge Biotechnologies is a biotechnology company.
Where is Refuge Biotechnologies headquartered?
Refuge Biotechnologies is headquartered in Menlo Park, US.
Which VCs invest in companies like Refuge Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Refuge Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Refuge Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.